Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts. (Q33630104)

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

title

Growth suppressive effect of pegylated arginase in malignant pleural mesothelioma xenografts (English)

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

malignant pleural mesothelioma

1 reference

8

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

author name string

Sze-Kwan Lam

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

Yuan-Yuan Li

2

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

Shi Xu

3

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

Leanne Lee Leung

4

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

Kin-Pong U

5

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

Yan-Fang Zheng

6

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

Paul Ning-Man Cheng

7

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

publication date

2 May 2017

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

volume

18

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

issue

1

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

19 March 2020

page(s)

80

1 reference

https://www.ebi.ac.uk/europepmc/webservices/rest/search?query=EXT_ID:28464918 AND SRC:MED&resulttype=core&format=json

Arginine Deprivation With Pegylated Arginine Deiminase in Patients With Argininosuccinate Synthetase 1-Deficient Malignant Pleural Mesothelioma: A Randomized Clinical Trial.

19 March 2020

cites work

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

The 2015 World Health Organization Classification of Tumors of the Pleura: Advances since the 2004 Classification

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Management of Chemotherapy Induced Nausea and Vomiting in Patients on Multiday Cisplatin Based Combination Chemotherapy

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Targeting arginine metabolism pathway to treat arginine-dependent cancers.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Arginine dependence of acute myeloid leukemia blast proliferation: a novel therapeutic target.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Preliminary efficacy, safety, pharmacokinetics, pharmacodynamics and quality of life study of pegylated recombinant human arginase 1 in patients with advanced hepatocellular carcinoma

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Ki67 is a promising molecular target in the diagnosis of cancer (review).

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Downregulation of thymidylate synthase and E2F1 by arsenic trioxide in mesothelioma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Erlotinib-induced autophagy in epidermal growth factor receptor mutated non-small cell lung cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Anti-tumor efficacy of a recombinant human arginase in human hepatocellular carcinoma.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Generation of a selectively cytotoxic fusion protein against p53 mutated cancers

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Recombinant human arginase inhibits the in vitro and in vivo proliferation of human melanoma by inducing cell cycle arrest and apoptosis.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Arginine deprivation and argininosuccinate synthetase expression in the treatment of cancer.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Recombinant human arginase inhibits proliferation of human hepatocellular carcinoma by inducing cell cycle arrest

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Malignant pleural mesothelioma: clinicopathologic and survival characteristics in a consecutive series of 394 patients.

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Dose translation from animal to human studies revisited

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Pegylated arginine deiminase: a novel anticancer enzyme agent

21 June 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Human recombinant arginase I(Co)-PEG5000 [HuArgI(Co)-PEG5000]-induced arginine depletion is selectively cytotoxic to human acute myeloid leukemia cells

21 June 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/S12931-017-0564-3

A new prognostic score system in patients with advanced hepatocellular carcinoma not amendable to locoregional therapy: implication for patient selection in systemic therapy trials.

21 January 2018

1 reference

Crossref

https://api.crossref.org/works/10.1186/S12931-017-0564-3

Effects of treatment regimens on survival in patients with malignant pleural mesothelioma.

21 January 2018

1 reference

https://eutils.ncbi.nlm.nih.gov/entrez/eutils/elink.fcgi?dbfrom=pmc&linkname=pmc_refs_pubmed&retmode=json&id=5414232

Kidney tubular toxicity of maintenance pemetrexed therapy

30 October 2018

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28464918

12 December 2020

inferred from PubMed ID database lookup

Pegylated recombinant human arginase (rhArg-peg5,000mw) inhibits the in vitro and in vivo proliferation of human hepatocellular carcinoma through arginine depletion

1 reference

PubMed

https://pubmed.ncbi.nlm.nih.gov/28464918

12 December 2020

inferred from PubMed ID database lookup

Identifiers

DOI

10.1186/S12931-017-0564-3

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qwzntcblgfhsnfutqxel5xv6aq

30 July 2022

Dimensions Publication ID

1 reference

https://scigraph.springernature.com/pub.10.1186/s12931-017-0564-3

release_qwzntcblgfhsnfutqxel5xv6aq

9 September 2019

Fatcat ID

1 reference

Fatcat

https://api.fatcat.wiki/v0/release/qwzntcblgfhsnfutqxel5xv6aq

30 July 2022

https://api.fatcat.wiki/v0/release/qwzntcblgfhsnfutqxel5xv6aq

1 reference

30 July 2022

https://api.fatcat.wiki/v0/release/qwzntcblgfhsnfutqxel5xv6aq

PubMed publication ID

1 reference

30 July 2022